FDA Widens Use of Ivacaftor Again for Cystic Fibrosis FDA Widens Use of Ivacaftor Again for Cystic Fibrosis

In what is hailed as a victory for precision medicine, the agency expanded the drug ' s indication to cover more gene mutations that cause the life-shortening disorder.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news